A single amino-acid substitution in the EP2 prostaglandin receptor confers responsiveness to prostacyclin analogs

Molecular Pharmacology

Volumn 54, Issue 3, 1998, Pages 584-590

  Kedzie, Karen M ^a   Donello, John E ^a   Krauss, Heather A ^a   Regan, John W ^b   Gil, Daniel W ^a  

^a ALLERGAN INC   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTACYCLIN DERIVATIVE; PROSTAGLANDIN E RECEPTOR;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; HUMAN; HUMAN CELL; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; RECEPTOR AFFINITY; RECEPTOR INTRINSIC ACTIVITY; SITE DIRECTED MUTAGENESIS;

EID: 0031663772     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.54.3.584     Document Type: Article

References (18)

1. 3 receptor. Mol Pharmacol 57:61-68.
2. Boie Y, Rushmore TH, Darmon-Goodwin A, Grygorczyk R, Sliptez DM, Metters KM, and Abramovitz M (1994) Cloning and expression of a cDNA for the human prostanoid IP receptor. J Biol Chem 269:12173-12178.
3. 3 subtype. Biochem J 322:597-601.
4. Delegeane AM, Ferland LH, and Mellon PA (1987) Tissue-specific enhancer of the human glycoprotein hormone α-subunit gene: dependence on cyclic AMP-inducible elements. Mol Cell Biol 7:3994-4002.
5. 2 receptor allows discrimination between agonist and antagonist binding sites. Mol Pharmacol 44:934-939.
6. 3 subtype in insect cells. Biochem J 307:493-498.
7. Kobayashi T, Kiriyama M, Hirata T, Hirata M, Ushikubi F, and Narumiya S (1997) Identification of domains conferring ligand binding specificity to the prostanoid receptor. Studies on chimeric prostacyclin/prostaglandin D receptors. J Biol Chem 272:15154-15160.
8. Krystek S, Patel PS, Rose PM, Fisher SM, Kienzle B, Lach DA, Liu EC-K, Lynch JS, Novotny J, and Webb ML (1994) Mutation of peptide binding site in transmembrane region of a G protein-coupled receptor accounts for endothelin receptor subtype selectivity. J Biol Chem 269:12383-12386.
9. Kunkel TA (1985) Rapid and efficient site-specific mutagenesis without phenotypic selection. Proc Natl Acad Sci USA 82:488-492.
10. Lee JA, Elliott JD, Sutiphong JA, Friesen WJ, Ohlstein EH, Stadel JM, Gleason JG, and Pieshoff CE (1994) Tyr-129 is important to the peptide ligand affinity and selectivity of human endothelin type A receptor. Proc Natl Acad Sci USA 91:7164-7168.
11. s through interaction of α-carboxylic acid of agonist and arginine residue of seventh transmembrane domain. J Biol Chem 270:16122-16127.
12. Nielsen D, Chang T-C, and Shapiro DJ (1989) A highly sensitive, mixed-phase assay for chloramphenicol acetyltransferase activity in transfected cells. Anal Biochem 179:19-23.
13. 4, differ in desensitization and sensitivity to the metabolic inactivation of the agonist. Mol Pharmacol 50:1031-1037.
14. Ozenberger BA and Hadcock JR (1995) A single amino acid substitution in somatostatin receptor subtype 5 increases affinity for somatostatin-14. Mol Pharmacol 47:82-87.
15. Pierce KL, Gil DW, Woodward DF, and Regan JR (1995) Cloning of human prostanoid receptors. Trends Pharmacol Sci 16:253-256.
16. 2 subtype. Mol Pharmacol 46:213-220.
17. Toh H, Ichikawa A, and Narumiya S (1995) Molecular evolution of receptors for eicosanoids. FEBS Lett 361:17-21.
18. 2 receptor antagonist. Biochem Pharmacol 50:1731-1733.